CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM
Total 13F shares
20,437,523
Share change
+1,576,756
Total reported value
$63,151,654
Price per share
$3.09
Number of holders
49
Value change
+$4,853,188
Number of buys
24
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q4 2019

As of 31 Dec 2019, CASI PHARMACEUTICALS INC - COM (CASI) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,437,523 shares. The largest 10 holders included IDG-Accel China Growth Fund III Associates L.P., BlackRock Inc., VANGUARD GROUP INC, Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and Nuveen Asset Management, LLC. This page lists 49 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.